Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Lymphoma, Large B-Cell, Diffuse

Pancreatic Neoplasms

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung

Leukemia, Monocytic, Acute

Leukemia, Myeloid, Acute

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

HR+/HER2- Advanced Breast Cancer

Lymphoma, T-Cell, Peripheral

Triple Negative Breast Neoplasms

Advanced Colorectal Cancer in the Third-line Treatment and Beyond

Lymphoma, Large B-Cell, Diffuse

Recurrence, Lymphoma, T-Cell, Peripheral

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Urinary Bladder Neoplasms

Colorectal Cancer Metastatic

Sarcoma, Osteosarcoma

Lymphoma, T-Cell, Peripheral

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lymphoma, Large B-Cell, Diffuse

Colonic Neoplasms

Osteosarcoma

Breast Neoplasms

Lymphoma, Large B-Cell, Diffuse

HR+/HER2- Advanced Breast Cancer

Lymphoma, T-Cell, Peripheral

Colorectal Neoplasms

Recurrence, Leukemia, Myeloid, Acute

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

HR+/HER2- Breast Cancer

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Breast Neoplasms

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Clinical Trials

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

CM-AML-001

HBI-8000

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

HiR+X

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Chidamide Combined With Toripalimab in Sarcoma

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

NeoTEE

Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

TRUMP

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade